ListedSMEAMBEY
Ambey Laboratories Limited
Ambey Laboratories Limited is a sme IPO raising ₹45 Cr at ₹65 – ₹68 a share. It listed on 11 Jul 2024 and trades at ₹18 today, −73.1% against its issue price of ₹68. It was subscribed 0.00× in total.
₹68
Issue price
₹18
Price now
−73.1%
Since issue price
11 Jul 2024
Listed on
0.00×Subscribed (final) · all exchanges
No bids yet
populated partly populated we hold nothing here — the tab says why
Who bid for it
| Investor category | Shares offered | Shares bid for | Subscribed |
|---|---|---|---|
| QIB Banks, funds and other large institutions | 0 | 7,74,96,000 | 0.00× |
| Foreign Institutional Investors | no separate quota | 2,43,14,000 | n/a |
| Domestic Financial Institutions | no separate quota | 84,56,000 | n/a |
| Mutual funds | no separate quota | 0 | n/a |
| Others | no separate quota | 4,47,26,000 | n/a |
| Non-institutional Wealthy individuals and companies bidding above ₹2 lakh | 0 | 19,68,06,000 | 0.00× |
| Corporates | no separate quota | 91,00,000 | n/a |
| Individuals | no separate quota | 18,66,10,000 | n/a |
| others | no separate quota | 10,96,000 | n/a |
| Retail Ordinary investors bidding up to ₹2 lakh | 0 | 42,60,14,000 | 0.00× |
| Cut Off | no separate quota | 22,21,00,000 | n/a |
| Price bids | no separate quota | 20,39,14,000 | n/a |
| Total | 0 | 70,03,16,000 | 0.00× |
Sub-categories read no separate quota rather than a dash: the exchange publishes bids at that level but never a reservation against them, so a subscription multiple does not exist — it is not missing data. Bids across both exchanges (NSE and BSE) — the figure usually quoted publicly. Last updated 25 Jul, 06:48 pm IST.
How demand built
We hold no subscription readings for this issue.